{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:41:50Z","timestamp":1777678910181,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.det.2010.01.015","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T11:18:40Z","timestamp":1273058320000},"page":"367-370","source":"Crossref","is-referenced-by-count":26,"title":["Fibroblast-Based Cell Therapy Strategy for Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"28","author":[{"given":"W.F.","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.det.2010.01.015_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2230.2002.01130.x","article-title":"Epidermolysis bullosa and cancer","volume":"27","author":"Mallipeddi","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.015_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2006-923991","article-title":"Effective esophageal balloon dilation for esophageal stenosis in recessive dystrophic epidermolysis bullosa","volume":"16","author":"Okada","year":"2006","journal-title":"Eur J Pediatr Surg"},{"issue":"3","key":"10.1016\/j.det.2010.01.015_bib3","first-page":"677","article-title":"The risk of cardiomyopathy in inherited epidermolysis bullosa","volume":"159","author":"Fine","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1365-2133.2005.07123.x","article-title":"Bone mineralization in children with epidermolysis bullosa","volume":"154","author":"Fewtrell","year":"2006","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.015_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2230.2004.01485.x","article-title":"Oro-dental manifestations in Hallopeau-Siemens-type recessive dystrophic epidermolysis bullosa","volume":"29","author":"De Benedittis","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.01.015_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.01.015_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2003.08.008","article-title":"Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin","volume":"50","author":"Fine","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2133.1985.tb15260.x","article-title":"Proteases are responsible for blister formation in recessive dystrophic epidermolysis bullosa and epidermolysis bullosa simplex","volume":"112","author":"Takamori","year":"1985","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.01.015_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1357-4310(97)01112-X","article-title":"Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity","volume":"3","author":"Uitto","year":"1997","journal-title":"Mol Med Today"},{"issue":"2","key":"10.1016\/j.det.2010.01.015_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00196781","article-title":"The molecular basis for inherited bullous diseases","volume":"74","author":"Korge","year":"1996","journal-title":"J Mol Med"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.1995.tb00717.x","article-title":"Defective in vivo expression and apparently normal in vitro expression of a newly identified 105-kDa lower lamina lucida protein in dystrophic epidermolysis bullosa","volume":"132","author":"Chan","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.01.015_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/1523-1747.ep12265460","article-title":"Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis by a quantitative ultrastructural technique","volume":"84","author":"Tidman","year":"1985","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.01.015_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: pathogenesis and clinical features","volume":"28","author":"Bruckner-Tuderman","year":"2010","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.det.2010.01.015_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","article-title":"Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa","volume":"28","author":"Chung","year":"2010","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.det.2010.01.015_bib15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.01.015_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.jid.5700216","article-title":"Fibroblasts as target cells for DEB gene therapy","volume":"126","author":"Chen","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.01.015_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1172\/JCI115680","article-title":"Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils","volume":"89","author":"Ryyn\u00e4nen","year":"1992","journal-title":"J Clin Invest"},{"issue":"16","key":"10.1016\/j.det.2010.01.015_bib18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1089\/104303400750035771","article-title":"Virus-mediated gene transfer for cutaneous gene therapy","volume":"11","author":"Ghazizadeh","year":"2000","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.det.2010.01.015_bib20","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/sj.jid.5700435","article-title":"Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients","volume":"126","author":"Goto","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.015_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200317193","article-title":"Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue","volume":"111","author":"Ortiz-Urda","year":"2003","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib22","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.det.2010.01.015_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.det.2010.01.015_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol Ther"},{"issue":"9","key":"10.1016\/j.det.2010.01.015_bib25","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/jid.2008.216","article-title":"Epidermolysis bullosa: prospects for cell-based therapies","volume":"128","author":"Uitto","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.01.015_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaad.2003.08.013","article-title":"Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa","volume":"50","author":"Hasegawa","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.01.015_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10047-008-0406-7","article-title":"Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg","volume":"11","author":"Yamada","year":"2008","journal-title":"J Artif Organs"},{"key":"10.1016\/j.det.2010.01.015_bib28","first-page":"S28","article-title":"Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts randomized against placebo injections","volume":"129","author":"Yan","year":"2009","journal-title":"J Invest Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T10:51:13Z","timestamp":1544525473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0733863510000161"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.01.015","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}